Aandeel ORIAU ORION BIOTECH OPPORTUNITIES CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Orion Biotech Opportunities Corp. OTC Markets

Aandelen

ORIAU

KYG6780C1252

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Orion Biotech Opportunities Corp.(OTCPK:ORIA) dropped from NASDAQ Composite Index
Orion Biotech Opportunities : will redeem its Public Shares and will not consummate an initial business combination - Form 8-K
ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Auditor Raises 'Going Concern' Doubt
Orion Biotech Opportunities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Orion Biotech Opportunities Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
ORION BIOTECH OPPORTUNITIES CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Certain Class B Ordinary Shares of Orion Biotech Opportunities Corp. are subject to a Lock-Up Agreement Ending on 9-NOV-2021.
ORION BIOTECH OPPORTUNITIES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 million.
Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 million.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ORIA
  4. Koers ORIAU
  5. Nieuws Orion Biotech Opportunities Corp.
  6. Andere talen